rs1554942980
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_001112704.2(VAX1):c.312dupC(p.Thr105HisfsTer34) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001112704.2 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
VAX1 | ENST00000369206.6 | c.312dupC | p.Thr105HisfsTer34 | frameshift_variant | Exon 2 of 3 | 5 | NM_001112704.2 | ENSP00000358207.4 | ||
VAX1 | ENST00000277905.6 | c.312dupC | p.Thr105HisfsTer34 | frameshift_variant | Exon 2 of 4 | 1 | ENSP00000277905.2 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Microphthalmia, syndromic 11 Uncertain:1
This sequence change inserts 1 nucleotide in exon 2 of the VAX1 mRNA (c.312dupC), causing a frameshift at codon 105. This creates a premature translational stop signal (p.Thr105Hisfs*34) and is expected to result in an absent or disrupted protein product. This variant is not present in population databases (ExAC no frequency) and has not been reported in the literature in individuals with a VAX1-related disease. The current clinical and genetic evidence is not sufficient to establish whether loss-of-function variants in VAX1 cause disease. Therefore, this variant has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at